Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

News To Note For July 14, 2020

Proscia
By Author Proscia | July 15, 2020

Philadelphia-based Proscia Inc., a provider of artificial intelligence-enabled pathology solutions, has received Medical Device Single Audit Program certification, accelerating its expansion in the global diagnostic pathology market.

Our website uses cookies. By using this site, you agree to its use of cookies.